- Home
- NYXH vs NVX Comparison
NYXH vs NVX Comparison
Compare NYXH & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYXH
- NVX
- Stock Information
- Founded
- NYXH 2009
- NVX 2012
- Country
- NYXH Belgium
- NVX Australia
- Employees
- NYXH N/A
- NVX N/A
- Industry
- NYXH Medical/Dental Instruments
- NVX Industrial Machinery/Components
- Sector
- NYXH Health Care
- NVX Miscellaneous
- Exchange
- NYXH Nasdaq
- NVX Nasdaq
- Market Cap
- NYXH 261.1M
- NVX 176.5M
- IPO Year
- NYXH 2021
- NVX N/A
- Fundamental
- Price
- NYXH $9.54
- NVX $1.96
- Analyst Decision
- NYXH Strong Buy
- NVX Strong Buy
- Analyst Count
- NYXH 5
- NVX 1
- Target Price
- NYXH $17.00
- NVX $4.00
- AVG Volume (30 Days)
- NYXH 171.0K
- NVX 59.3K
- Earning Date
- NYXH 11-06-2024
- NVX 01-01-0001
- Dividend Yield
- NYXH N/A
- NVX N/A
- EPS Growth
- NYXH N/A
- NVX N/A
- EPS
- NYXH N/A
- NVX N/A
- Revenue
- NYXH $5,134,469.00
- NVX $6,875,112.00
- Revenue This Year
- NYXH $49.72
- NVX $89.31
- Revenue Next Year
- NYXH $395.59
- NVX $410.89
- P/E Ratio
- NYXH N/A
- NVX N/A
- Revenue Growth
- NYXH 57.79
- NVX 19.05
- 52 Week Low
- NYXH $4.00
- NVX $1.40
- 52 Week High
- NYXH $20.00
- NVX $3.10
- Technical
- Relative Strength Index (RSI)
- NYXH 63.88
- NVX 51.84
- Support Level
- NYXH $9.23
- NVX $1.90
- Resistance Level
- NYXH $10.12
- NVX $2.49
- Average True Range (ATR)
- NYXH 0.50
- NVX 0.13
- MACD
- NYXH -0.00
- NVX 0.00
- Stochastic Oscillator
- NYXH 64.20
- NVX 22.06
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About NVX NOVONIX Limited American Depository Shares
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration and Mining, Battery Technology, and NOVONIX Anode Materials. Graphite Exploration and Mining segment is engaged in the exploration and development of high-grade flake graphite deposits. The NOVONIX Anode Materials segment develops and manufactures battery anode materials. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Technology segment generates maximum revenue for the company.